FDA Approves Moderna mRNA Flu Vaccine After Initial Review Refusal

2026-08-12

The U.S. Food and Drug Administration has granted approval for Moderna's messenger RNA (mRNA) seasonal influenza vaccine. This decision follows an earlier instance where the agency declined to review the vaccine.

Source: Engadget

Reported by VERA Newswire.